Manages pain severe enough to require an opioid analgesic. ANDA 74653, held by Hikma. Hydromorphone Hydrochloride.
As of Nov 16, 2026, ANDA 74653 (Hydromorphone Hydrochloride), held by Hikma, was first approved by FDA on Jul 29, 1998, with 11 approved supplements and 0 published complete response letters.
Hydromorphone Hydrochloride Oral Solution and Hydromorphone Hydrochloride Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including Hydromorphone Hydrochloride Oral Solution and Hydromorphone Hydrochloride Tablets, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 29, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydromorphone Hydrochloride5MG/5ML · solution;oral | Hydromorphone Hydrochloride | Rx |
| Sep 10, 2026 | Supplement 15Labeling · Standard review | Approved | None posted |
| Sep 10, 2026 | Supplement 18Labeling · Standard review | Approved | None posted |
| Sep 10, 2026 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jun 18, 2026 | Supplement 21REMS | Approved | None posted |
| Oct 31, 2024 | Supplement 17REMS | Approved | None posted |
| Apr 10, 2020 | Supplement 11Labeling · Standard review | Approved | None posted |
| Apr 10, 2020 | Supplement 14Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 9REMS | Approved | None posted |
| Oct 31, 2017 | Supplement 7Labeling · Standard review | Approved | None posted |
| Oct 18, 1999 | Supplement 2Manufacturing | Approved | None posted |
| May 11, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Jul 29, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters